Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Exicure, Inc. Exicure, Inc. Announces 1-for-5 Reverse Stock Split August 26, 2024 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting August 19, 2024 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting August 15, 2024 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Reports Second Quarter 2024 Financial Results August 13, 2024 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics August 08, 2024 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Receives Positive Listing Determination from Nasdaq August 01, 2024 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Reports First Quarter 2024 Financial Results June 17, 2024 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Reports Full Year 2023 Financial Results June 06, 2024 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Received Nasdaq Notice of a Delisting Determination May 23, 2024 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Reports Third Quarter 2023 Financial Results May 16, 2024 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K April 22, 2024 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis February 05, 2024 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q November 28, 2023 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors August 23, 2023 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update August 11, 2023 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update July 14, 2023 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives May 26, 2023 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q May 19, 2023 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld May 04, 2023 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors April 27, 2023 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate Update March 27, 2023 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Announces Closing of Private Placement Transaction with CBI USA, Inc. and Changes to the Board of Directors February 24, 2023 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements December 14, 2022 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update November 14, 2022 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives September 26, 2022 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure Announces Presentation at Chardan’s 6th Annual Genetic Medicines Conference September 01, 2022 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress August 15, 2022 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement July 20, 2022 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split June 29, 2022 From Exicure, Inc. Via Business Wire Tickers XCUR Exicure, Inc. Announces Adjournment of Annual Meeting of Stockholders May 27, 2022 From Exicure, Inc. Via Business Wire Tickers XCUR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.